中华医学美学美容杂志
中華醫學美學美容雜誌
중화의학미학미용잡지
CHINESE JOURNAL OF MEDICAL AESTHETICS AND COSMETOLOGY
2013年
5期
323-325
,共3页
穆大力%栾杰%穆兰花%辛敏强%刘春军
穆大力%欒傑%穆蘭花%辛敏彊%劉春軍
목대력%란걸%목란화%신민강%류춘군
组织外扩张%自体脂肪颗粒注射移植%隆乳术
組織外擴張%自體脂肪顆粒註射移植%隆乳術
조직외확장%자체지방과립주사이식%륭유술
External tissue expansion%Autologous fat transfer%Breast augmentation
目的 探讨采用组织外扩张技术进行自体脂肪颗粒注射移植隆乳术的疗效及安全性.方法 进行自体脂肪颗粒注射隆乳术前,佩戴组织外Brava扩张器1个月,每天佩戴8 h,以增加乳房组织容积并改善血供.重复扩张与脂肪注射移植2~3次.结果 自2010年l~10月,采用组织外扩张自体脂肪颗粒移植隆乳术26例,获得良好隆乳效果,术后随访1个月至1年,未发现结节、硬块及囊肿等并发症.结论 以组织外扩张进行自体脂肪颗粒移植隆乳术,可以有效地增大乳房受区的容积及血管化程度,因而可以增加乳房内注射的脂肪量并提高脂肪的存活率,是一项提高自体脂肪颗粒注射隆乳效果的理想方法.
目的 探討採用組織外擴張技術進行自體脂肪顆粒註射移植隆乳術的療效及安全性.方法 進行自體脂肪顆粒註射隆乳術前,珮戴組織外Brava擴張器1箇月,每天珮戴8 h,以增加乳房組織容積併改善血供.重複擴張與脂肪註射移植2~3次.結果 自2010年l~10月,採用組織外擴張自體脂肪顆粒移植隆乳術26例,穫得良好隆乳效果,術後隨訪1箇月至1年,未髮現結節、硬塊及囊腫等併髮癥.結論 以組織外擴張進行自體脂肪顆粒移植隆乳術,可以有效地增大乳房受區的容積及血管化程度,因而可以增加乳房內註射的脂肪量併提高脂肪的存活率,是一項提高自體脂肪顆粒註射隆乳效果的理想方法.
목적 탐토채용조직외확장기술진행자체지방과립주사이식륭유술적료효급안전성.방법 진행자체지방과립주사륭유술전,패대조직외Brava확장기1개월,매천패대8 h,이증가유방조직용적병개선혈공.중복확장여지방주사이식2~3차.결과 자2010년l~10월,채용조직외확장자체지방과립이식륭유술26례,획득량호륭유효과,술후수방1개월지1년,미발현결절、경괴급낭종등병발증.결론 이조직외확장진행자체지방과립이식륭유술,가이유효지증대유방수구적용적급혈관화정도,인이가이증가유방내주사적지방량병제고지방적존활솔,시일항제고자체지방과립주사륭유효과적이상방법.
Objective To observe the clinical effects of autologous fat injection augmentation with external tissue expander.Methods 26 cases wore the Brava device,a bra-like vacuum-based external tissue expander for 4 weeks before autologous fat injection augmentation.Patients resumed Brava wear for 14 more days after fat injection.Results 26 women had a mean augmentation volume at 3 months of 76 ml per breast after single fat injection.Follow-up ranged from 1 month to 12 months.There were no complications such as nodules,masses,or cysts occurred.Patient satisfaction was as sessed:25 cases (95.6 %) were satisfied with the cosmetic results.Conclusions The addition of Brava expansion before autologous fat grafting leads to significantly larger breast augmentations,with more fat graft placement,higher graft survival rates,and minimal graft necrosis or complications,demonstrating high safety and efficacy for the procedure.